Opioid Conversion (with cross-tolerance reduction)
Morphine-equivalent conversion across morphine, oxycodone, hydromorphone, hydrocodone, and fentanyl patch with explicit 25–50% cross-tolerance reduction.
Sum of all doses in 24 hr
Input MME / day
60MME
After reduction
40MME
| Drug | Raw equivalent | After reduction |
|---|---|---|
| Morphine PO | 60mg/day | 40mg/day |
| Morphine IV/SC | 20mg/day | 13mg/day |
| Oxycodone PO | 40mg/day | 27mg/day |
| Hydromorphone PO | 15mg/day | 10mg/day |
| Hydromorphone IV/SC | 3mg/day | 2mg/day |
| Hydrocodone PO | 60mg/day | 40mg/day |
| Codeine PO | 400mg/day | 270mg/day |
| Tramadol PO | 600mg/day | 400mg/day |
| Fentanyl transdermal | 25mcg/hr | 16.8mcg/hr |
| Tapentadol PO | 150mg/day | 100mg/day |
Fentanyl patch — nearest strength: 12 mcg/hr
Fentanyl patch conversions are nonlinear and conservative. Available strengths: 12, 25, 37.5, 50, 75, 100 mcg/hr. When initiating a patch, plan for an 18–24 hour onset and a 12–24 hour offset after removal.
Methadone is not a linear conversion
Methadone is intentionally omitted from this tool. Its conversion ratio depends on the starting MME (the higher the dose, the more potent methadone becomes — sometimes 1:20 at higher MMEs), and it has unique QT and respiratory risks. Methadone rotation is a specialist task — pain or palliative care should drive it.
Always reduce 25–50% for incomplete cross-tolerance
Tolerance is opioid-specific only in part. When rotating between agents, the new drug typically appears more potent than the table predicts. Standard practice is to reduce the calculated equivalent dose by 25–50% (33% is a reasonable default), then titrate to effect. In opioid-naïve patients or those with respiratory comorbidities, reduce by 50%.